Home / Transcripts / Tyson Foods, Inc. (TSN) · May 4, 2026

Tyson Foods, Inc. (TSN) Earnings Call Transcript & Summary

May 4, 2026

New York Stock Exchange US Consumer Staples Food Products earnings 65 min

What were the key takeaways from Tyson Foods, Inc.'s May 4, 2026 earnings call?

In the second quarter of fiscal year 2026, Tyson Foods, Inc. reported revenues of $13.7 billion and adjusted operating income of $497 million, reflecting a solid performance driven by strong demand across its protein segments. Management raised the adjusted operating income guidance for the full year to a range of $2.2 billion to $2.4 billion, indicating confidence in continued operational improvements and market demand. The Chicken segment performed particularly well, with operating income of $523 million and a margin of 12.2%, highlighting the effectiveness of Tyson's strategic initiatives.

What topics did Tyson Foods, Inc. cover?

What were Tyson Foods, Inc.'s May 4, 2026 results?

Tyson Foods' strong second quarter performance and raised guidance signal a positive outlook for the remainder of fiscal 2026. Investors should monitor the execution of operational improvements, particularly in the Beef segment, and the continued strength in Chicken and Prepared Foods. The company's diversified protein portfolio and strategic customer relationships position it well for future growth, but risks remain tied to commodity price volatility and market conditions.

Earnings Call Speaker Segments

Jon Kathol executive
#1

Hello, and thanks for joining us for Tyson Foods' conference call covering results from the second quarter of fiscal year 2026. Presenting today, we have Donnie King, who serves as President and Chief Executive Officer of Tyson Foods, along with Curt Calaway, our Chief Financial Officer, and Devin Cole, our Chief Operating Officer — each will deliver prepared remarks. Once those remarks conclude, a Q&A session will follow; in addition, a supplemental presentation has been made available, and it might be referenced during this call — you can find it on Tyson's Investor Relations website or through the link provided in our webcast. Throughout this call, statements will be made about what we expect looking ahead. Any such forward-looking statements shared today are offered under the safe harbor protections established by the Private Securities Litigation Reform Act of 1995. When we talk about forward-looking statements, we mean every comment describing our expectations, assumptions or beliefs regarding events or performance still to come, rather than matters that are purely historical; such statements carry risks, uncertainties and assumptions that could lead actual results to diverge materially from what we currently project. For more details on risk factors that might cause actual outcomes to differ materially from our projections, please see our forward-looking statement disclaimers on Slide 2, along with our SEC filings. We undertake no duty to revise any forward-looking statements. As noted during the prior quarter, segment results appear at a segment operating income level and will be addressed on an adjusted basis. The key distinction between segment operating income and how it was handled in earlier quarters is that corporate expenses and amortization are no longer pushed down to the segment level. We have restated quarterly results reported previously across the last 3 fiscal years so they match the new format. This segment change makes no difference to consolidated historical U.S. GAAP financial results. You can access the recast financial information via the Events and Presentations section on the company's Investor Relations website at ir.tyson.com. Keep in mind that whenever earnings per share, segment operating income, operating income and operating margin come up in our remarks, those figures are adjusted for our fiscal periods unless stated otherwise. Reconciliations tying these non-GAAP measures to their corresponding GAAP measures can be found in our earnings press release. At this point, I'll hand the call over to Donnie.

Donnie King executive
#2

Thanks, Jon, and I appreciate everyone who’s with us today. Taking a look at the second quarter as a whole, I feel good about what we delivered, and we’re lifting our AOI outlook for the full year to reflect stronger results so far this year along with our ongoing belief in where this business is headed. I want to underscore what we’re creating here at Tyson: a diversified, protein-focused company built to meet rising appetite for premium protein. Animal protein is still front and center for shoppers and keeps building momentum as a core element of a nutritious diet; we’re connected directly to that long-term trend and positioned to gain from it. Our attention is on consistent execution, a varied multi-protein lineup and a measured strategy for deploying capital. The scale we have and the way we operate let us generate cash through different cycles, which allows us to put money back into the business, bring leverage down as time goes on and give capital back to shareholders, in line with our capital priorities. We’re staying the course on our long-term plan that delivers value for customers, consumers and shareholders, and we’ll keep being open with our investors throughout. The move to segment operating income is delivering the results we wanted; this shift gives our business leaders the ability to chase volume growth and make sharper choices from a clearer picture of how those choices play out, absent corporate expenses and amortization, which tend to be more fixed. As we’ve said before, we’ll keep concentrating on cutting costs and getting the most out of our corporate functions, and we believe there’s additional room to go on both fronts. Let me walk you through more on the quarter, and Devin and Curt will go into further detail. Our Q2 numbers, $13.7 billion in sales and $497 million in adjusted operating income, show that our strategy is delivering and building momentum for Tyson Foods and our customers alike; we’re keeping our eye on getting better all the time, and our team is excited about what’s in front of us. In Chicken, we turned in yet another strong quarter, posting $523 million in segment operating income and a 12.2% margin, all while dealing with a commodity environment that’s returned to more normal levels and the usual seasonality we see in Q2. Solid handling of what we can control, along with smarter marketing and promotional spending, lifted results. Demand is still solid and our focus on customers is paying off. All in, Chicken volume rose 1.7% versus a year ago, with retail and foodservice volumes climbing nearly 3x faster than overall volume, which shows the momentum we have with our strategic customers. What matters is that broad price hikes didn’t produce these numbers, since base pricing came in a bit lower during the quarter. Instead, we improved our product mix and ran things well operationally. Our end-to-end Chicken operation, which includes our Chicken genetics business, is delivering at a high standard as we keep meeting our commitments, and we still see plenty of room to improve and grow. Here’s one more case of a powerful Chicken business beating a commodity Chicken business. Turning to Prepared Foods. Segment operating income rose to $352 million, even with commodity costs up compared to last year, and our margin grew to 14%, on the strength of solid demand, share gains and disciplined execution. Revenue rose 4.8%, while volume was up 0.4%. What's key is that we keep pushing innovation forward, and our brands are coming out on top in the market. During Q2, we picked up share across volume, dollars and units. The power of our brands, our emphasis on customer relationships, better promotional efficiency and focused map investments are all producing a solid return on our investments. Now on to Beef. The results in our segment showed the swings in the cattle cycle that we had anticipated. We finished the strategic move we'd previously announced to streamline our manufacturing footprint. Because of that, only part of those operational adjustments shows up in our second quarter results, and the goal of those changes is better utilization and a stronger cost position. What's key is that we remain focused on what we can control — plant utilization, operating discipline, customer mix and execution — and we anticipate the gains from these steps will grow as the year goes on. For the rest of the year, our outlook points to smaller losses in the back half compared with the front half. Until cattle supplies return to normal, we still expect results under historical margin levels. Our Pork segment did well in a stable operating environment. Every part of the pork value chain, from hog supply and pork production to retail and foodservice customers, is fairly balanced, which lets operating margins be more predictable and stable. Pork's relative value versus beef should help revenue for the remainder of the year. Last, our International segment kept up its momentum and delivered another solid quarter. As we've said before, demand for protein keeps rising, and that helps us generate strong revenue and cash flow through both good and bad economic times. We also gain from producing multiple animal proteins, since the timing of those cycles differs; that pattern shields us from a macro environment that would otherwise be fragile. Consumer confidence lately dropped to a record low, and inflation remains elevated at more than 3%. Meanwhile, foodservice traffic bounced back during the second quarter, which underscores the worth of our diversified portfolio spanning retail and foodservice; we also gain from our scale, since we can offer lower unit costs, better service levels and hold a healthy market share as we turn out roughly 1 in 5 pounds of U.S. chicken, beef and pork. Our lengthy track record and strong marketplace position cement our business for the long haul. Protein remains a priority for consumers. As a top animal protein provider, we're positioned well to satisfy that demand with products offering complete nutrition, including all 9 essential amino acids. That, combined with our move toward simple ingredients, like the ones in your pantry, is connecting and building traction with consumers. Taken together, these elements underpin stronger returns via disciplined investment, growing profitability and consistent cash return to shareholders. Consumers are picking protein and gravitating toward brands they trust for quality, taste and convenience. That aligns squarely with Tyson Foods' strengths, where we're winning in Chicken and Prepared Foods by driving share, volume and margin. Nielsen's numbers show that for the 13 weeks that ended in March, retail volume across the total food and beverage category fell 1%, while dollars rose 1.7%. By comparison, our Tyson retail branded products — covering both our national and regional brands — posted gains of 2.3% in volume and 3.6% in dollars, beating those broader categories. Digital is another area where we're coming out ahead. At key retailers, our digital dollar growth is substantially better than what we see in-store, which speaks to our capacity to compete and win when shoppers buy across channels. Take a few illustrations: Tyson-branded value-added chicken rose 6.5%. Aidells dinner sausage was up 9.7%. Hillshire lunchmeat climbed 7.6%, and Wright and Jimmy Dean bacon rose 6.8%. Double-digit growth has also been reached by our Hillshire snack combos. Beyond that volume gain, dollars and share increased in all 5 categories, which confirms we're winning with consumers while making our growth higher quality; foodservice is going well too, with volume up 60 basis points. As for how innovation gets driven in our portfolio, we draw on AI derivative insights that make our identification of emerging preferences sharper and help turn those preferences into action. That lets us deliver on-trend, consumer-led products to the market.

Donnie King executive
#3

By applying AI, we're able to connect customer feedback directly with the products and dishes that end up on store shelves and restaurant menus. This technology is accelerating how quickly we move ideas through development, improving decisions around where to place products and how to price them, and boosting the impact of our marketing and efforts to win new buyers. Consider Jimmy Dean as one example. Using what these tools reveal, we're steering the next generation of breakfast options packed with extra protein. We recently introduced a Jimmy Dean protein breakfast line, and it has gotten off to an outstanding beginning — offering protein-rich takes on familiar items such as sandwiches and bowls, which are delivering better sales momentum and stronger customer purchases. Alongside those staples, we're adding new products such as Jimmy Dean high-protein waffles, which represent something fresh that grows our Prepared Foods division. The initial reaction from shoppers has been quite favorable, drawing in younger buyers who weren't previously connected to the brand. We've already started picking up a solid portion of retail share, and there's a strong opportunity ahead to keep building on that traction as we broaden where these products are sold and keep rolling out new ideas. When it comes to retail results, we continue to outperform our main rivals in similar parts of the business throughout the sector. In the last twelve months, our retail Prepared Foods segment has achieved significant improvements in volume, market share, and profitability, surpassing our competitors. Yet our valuation still shows a discount compared to those same peers. Those investors who see the worth now stand to gain the most. That's the reason Tyson Foods holds a distinctive advantage for thriving in the current climate. Interest in what we offer keeps expanding, and we are set up effectively to seize this momentum. Although certain businesses struggle to stimulate demand, the market share we've picked up proves both our resilience and our anticipation of additional expansion—a crucial factor behind our continued achievement. Because we focus on products built around protein and manage our money carefully, we can take advantage of chances created by solid results and keep succeeding in the market. We're a 90-year-old American business, so we offer reliability and steadiness no matter what part of the cycle we're in. You've heard us mention this often: we don't stay put. Taken together, these advantages let us create enduring worth for our customers, consumers, team members and shareholders. When we look forward, the possibilities in front of us have never been more encouraging, and my confidence in our portfolio and our strategy is extremely high. Having said that, I'll hand things to Devin, who will walk you through the segments in greater detail.

Devin Cole executive
#4

Appreciate that, Donnie, and good morning. During Q2, the team moved closer to the goals in our strategy. We stay dedicated to keeping ourselves answerable to what our customers and consumers anticipate. Let's now go through how each segment performed. Prepared Foods had a robust quarter, with sales rising 4.8% from a year earlier and volume increasing 0.4%. Operating income for the segment came to $352 million, a 7% gain versus the prior year, while margin widened to 14%, which shows ongoing advancement under our multiyear effort to boost profitability; we picked up share in volume, dollars and units. In the course of the quarter, our share of volume climbed 70 basis points, while dollar share was up 50 basis points, driven by strong demand for protein along with disciplined execution on our part, and we saw especially strong performance in bacon, lunchmeat, dinner sausage and snacking. The gain in volume stems from expanded distribution, new innovation and improved promotional efficiency, supported by targeted MAP spending, as shoppers gravitate toward convenient, nutritious options high in protein. Looking ahead, we expect segment operating income to grow further for the full year, and we remain well positioned in this business over the long term. Moving to Chicken, segment operating income came in at $523 million with a 12.2% margin, despite a pricing environment that has become more normalized and the typical seasonality we see in Q2. Revenue rose 3.5% compared with the prior-year period, driven by a beneficial mix and higher volumes, as overall Chicken volume increased 1.7%. Volumes in Retail and Foodservice grew at almost triple the rate of total volume, which shows strong consumer demand and momentum among our strategic customers. Although base pricing fell, our varied pricing approaches and enhanced mix kept average selling prices flat; that stability, together with our bottom-line results, stemmed from a better product mix tied to strategic customer expansion and stronger operational performance. Our execution on the controllable factors continued to improve. Better live results, improved yield, stronger use of assets, more productive labor, and tight control across the entire supply chain all played a part. Together they delivered a sixth straight quarter in which both volume and net sales rose compared with a year earlier, which shows just how steady and dependable the chicken side of our company is. We also want to highlight how well our Chicken genetics operation is doing — it is performing at a high level once again. That outcome reflects the dedication of our genetics and live production people, working alongside family farmers who excel at their craft. This operation is delivering solid, lasting results and creating genuine economic value for our customers. Along with moving toward a mix of products that carries more added value, the way we align with strategic customers and our Chicken Genetics operation distinguishes Tyson from rivals selling commodity chicken and reinforces the value we offer both customers and shareholders. We saw robust growth in retail and foodservice, and volume rose in virtually every subchannel. While we keep broadening our added-value and premium lineup to satisfy demand for convenient, high-quality choices, we are also improving service and quality for our strategic customers. All of this means our strategic customer partnerships and disciplined execution are making our Chicken business model stronger, and with that model growing more consistent and predictable, we believe there is additional runway in front of us. When it comes to our Beef segment, we're staying dedicated to running the business with discipline and focusing on what we can control, even as market conditions keep shifting. Beef sales were up just a bit in the second quarter versus the same period a year ago. Our revised operational footprint is now better matched to reduced cattle supplies, and the advantages of stronger capacity utilization are showing up. Although the quarter brought uneven industry conditions, we think the changes we made to our harvesting plan put us in a better spot to compete well both this year and long term, with a production footprint that's sized appropriately. We anticipate these moves will deliver growing benefits in the quarters ahead. Segment operating income came in lower than a year earlier, since elevated cattle costs outweighed the impact of higher cutout values, despite continued solid consumer demand. As we work through this cycle, we're staying dedicated to running our operations excellently across our footprint and pushing forward with further initiatives that help us achieve stronger and steadier long-term results. Turning to Pork, segment operating income reached $41 million, a margin of 2.6%, helped by greater sales that reflect robust consumer demand. Hog supplies at our facilities were sufficient for the quarter; thanks to dependable pork raw materials and a more tightly integrated network, we're enhancing mix and boosting value in Prepared Foods by getting higher utilization out of bellies, hands and trimmings. We'll keep striving for greater utilization because it will enhance access, quality and the landed cost of our raw materials. All in all, the incremental progress we made in the second quarter leaves me encouraged, and I'm confident there's room for us to grow and get better across the operational and controllable parts of our business in 2026 and beyond. Our attention is on our strategic customers and consumers while we deliver value to our shareholders. Since animal protein continues to be a clear favorite among consumers, the breadth of our portfolio lets us invest alongside our strategic customers to drive category expansion; with that, I'll hand things over to Curt to take you through our financial results and outlook in greater detail.

Curt Calaway executive
#5

Thank you, Devin. Because we are a large cap value business, our portfolio spanning multiple proteins and channels, along with the team's emphasis on running operations efficiently amid shifting macroeconomic conditions, delivered strong results relative to the broader food sector in the quarter. We believe additional opportunity lies ahead and feel good about how we will perform for the rest of the year; let's now turn to the numbers. In Q2, sales across the whole company rose 4.4%, reaching $13.7 billion versus the same period a year earlier, with Pork leading the way and Chicken plus Prepared Foods adding solid contributions, which shows the robust appetite for protein. Segment operating income for the second quarter came to $751 million, a bit above the comparable period last year. Corporate expenses and amortization rose by $19 million against the equivalent quarter a year ago. That climb stemmed from a $15 million gain on a legal settlement recorded last year, plus an $8 million loss tied to our deferred compensation plan this year. Excluding those two factors, it would have come in below the prior year. Adjusted operating income for the entire company was $497 million, equal to a 3.6% margin. Adjusted earnings per share in the quarter reached $0.87, a decline of 5% from a year ago. Now to our financial position. Our capital allocation philosophy stays disciplined, intentional and oriented toward the future, underpinned by a robust balance sheet. We keep our attention on preserving financial strength, putting money into the business and giving cash back to shareholders. Free cash flow matters greatly to our strategy, and we take encouragement from cash flow trends during the first half of the year. Cash from operations in that first half totaled $829 million, while capital expenditures came to $397 million, which left free cash flow at $432 million. We finished the quarter holding $3.7 billion in liquidity with net leverage at 2.2x; gross debt came down by close to $1 billion across the last 12 months, which includes a reduction of almost $300 million in this quarter alone. Given our robust cash flow, we kept buying back shares, repurchasing $92 million in the first half of the year, and once dividends of $353 million are included, we have given back $445 million to shareholders so far this year. Our balance sheet stays in good shape as we put priority on financial strength, our investment-grade credit rating and managing cash to build long-term shareholder value. Let's spend a moment going over our outlook for fiscal 2026. Keep in mind that our accounting cycle produces a 53-week year in fiscal '26 versus a 52-week year in fiscal '25. The 2026 outlook assumes a comparable 52-week year. We continue to expect full year sales to rise 2% to 4% year-over-year. We have lifted our range for total company adjusted operating income by $100 million at the midpoint, bringing the current range to $2.2 billion to $2.4 billion. We expect interest expense of roughly $365 million, which is $5 million below prior guidance, along with a tax rate near 25%. Our approach to cash management stays rigorous, with capital expenditures projected at $700 million to $1 billion, alongside improved free cash flow now sitting between $1.2 billion and $1.8 billion, reflecting our better financial results. Now, for additional detail on the segment outlook. Within Prepared Foods, we continue to anticipate segment operating income of $1.25 billion to $1.35 billion. Through the rest of the year, we'll keep pushing operational efficiencies and making strategic investments, staying on track with our plan. Given the robust performance in Chicken so far this year, we're raising our segment operating income expectation to a range of $1.9 billion to $2.05 billion, which represents a $200 million increase at the midpoint. We continue to see evidence that chicken will remain a favored protein in the year ahead, and we also anticipate that our operational execution and performance will stay at a high level. Given persistently tight cattle supply, we anticipate a segment operating loss in Beef of between $500 million and $350 million. This outlook captures our present assessment of cattle availability and spread conditions, partly offset by footprint actions taken in the second quarter and the operating discipline we currently have in place. Beef continues to be strategically vital to our multi-protein portfolio and customer relationships, and our focus is on long-term competitiveness. For Pork, our segment operating income outlook remains $250 million to $300 million, supported by sufficient hog supply, ongoing productivity and operational gains, and strong consumer demand for pork. Our International segment delivered results in line with expectations, and our annual outlook stays at $150 million to $200 million. Corporate expenses and amortization are expected to land between $950 million and $975 million, unchanged from prior guidance. All in all, I'm happy with how the second quarter went and remain confident that 2026 will be another strong year for the company. I'll now hand the call back to Donnie.

Donnie King executive
#6

Curt, thanks for that. During Q2, we stayed disciplined even as the macro backdrop kept shifting. Looking ahead to the back half of the year, our momentum gives us encouragement, and we see chances to lift our results. At the end of the day, what we deliver is premium protein that delivers on taste, offers nutrition, comes at a price people can afford, and fits easily into daily life. That central idea stays at the heart of how we operate and how we generate lasting wins and value. What we've achieved so far this year shows the dedication and sharp execution of our team members, and we plan to keep building on that momentum for the rest of fiscal 2026. With that said, I'll hand things back to Jon so we can kick off the Q&A.

Jon Kathol executive
#7

Thanks, Donnie. At this point we're going to take questions from the line. Just a reminder that the cautionary language about forward-looking statements and non-GAAP measures covers what we've just said as well as this Q&A. Operator, could you give the instructions for the Q&A?

Ben Theurer analyst
#8

Donnie, Devin, and Curt — before anything else, congratulations on those impressive results and on such a solid first half. My focus is really on Chicken. Could you walk us through how durable this performance is? Also, how much of a factor have genetics been over the last few months? And were there any one-time gains we ought to know about? That's my first question.

Donnie King executive
#9

Absolutely, Ben — I appreciate you asking. Let me begin with this quarter, where we delivered exactly what we told everyone we would. Net sales went up, margins got wider in Chicken and Prepared Foods, and we lifted our guidance for the whole year. Turning specifically to Chicken, when I look at our Q2, the results were excellent; we came in $112 million ahead of the equivalent quarter a year earlier; and honestly that breaks into 3 buckets, all of them central to the strategy we run. In our model, operational excellence matters enormously. That model centers on mix — specifically branded and value-added items, fresh plus frozen, along with strategic partnerships with customers. Later today I'll say more about the genetics side of our business. On Chicken performance overall, though, the word I'd use is consistency. We anticipate that the back half of '26 will resemble the front half closely. Our Chicken guidance midpoint moved up by $200 million, putting the range at $1.9 billion to $2.05 billion. The momentum here is genuine, I'd say; this company is stronger now than it has ever been; and we aren't counting on additional commodity tailwinds. What's driving this is execution, not commodity prices. Real conviction comes to us from strategic customer demand combined with operational momentum. We see this fiscal year finishing at or above the level of 2025. And I'd add that our start has been excellent. If I may use something as a proxy here: looking at the Q2-over-Q2 beat, it really splits into 3 buckets of roughly equal size. First is our commercial model — that means mix. Second is the partnerships we hold with our customers, our strategic ones; third is our genetics business. That genetics business is contributing visibly. Speaking to that point now — and I'll get into more detail shortly — it accounts for roughly 1/3 of the gap in their operational performance. This spans the entire chain; it isn't confined to what happens within the plant's 4 walls. From live production through the plants, the whole chain is where you see the performance. As I reviewed this, I also considered how commodity markets moved during the quarter — they dropped quite a bit; even so, our pricing models and similar tools let us offset those commodity market movements. Now, regarding the genetics business — actually, let me address this question first. You asked whether any one-time factors influenced these results that we ought to know about. The brief answer is none — what you're witnessing is our model functioning exactly as intended. Ordinarily I wouldn't discuss another company's operations, yet quite a bit has been published regarding a fire at Cook Foods. Honestly, my knowledge of that fire is quite limited, but plenty of conjecture has circulated suggesting our numbers benefited by taking on volume following the Cook fire. During our Q2, no volume at all is tied to the Cook fire. Then, looking ahead to the back half of the year, some additional volume might come our way since we possess the capacity, though I'd characterize that as nascent with respect to our total volume and its share of our branded value-added mix. Let me stop here and have you point me elsewhere.

Ben Theurer analyst
#10

Regarding the generics part, you mentioned you'd provide a bit more information — you made that promise.

Donnie King executive
#11

My apologies. Correct, correct. Pardon me. Our genetics operation lives within the Chicken division. It isn't its own reporting segment. It has existed there for quite a while; for us, it's unquestionably a strategic asset. Superior live performance and rear — genuine customer value — is what our next-generation genetics line delivers. Yet this gain likewise demands excellent execution, and that's what we're delivering too. We enjoyed a solid quarter, but that wasn't — neither Chicken nor genetics represented the entire picture. A bit on where our genetics operation has been and where it stands today. Regarding this genetics operation, we've been on a multiyear path during which we underperformed. Genetics for a large bird was something we lacked. What I'm sharing with you now, and what you should watch for going forward, is that I believe this shift is structural. Historically, our prior breed — aimed at a midsized, small-sized bird — had done well. In fact, it's doing even better now than it managed previously. Our fresh breed remains at a very early stage. This breed, as we might call it, has been tested and worked on by us for 5 years. Flowing through the pyramid takes considerable time. However, it's aimed more at a bigger bird, the large bird deboning segment we take part in — not to the degree that others do, yet that's what it's built for. So, what you're witnessing from these genetics figures ties almost entirely to the effect on the genetics company itself. The effect as it moves through the broilers or meat birds we raise isn't visible yet; we're at a very early point there, and I'd say low mid-single digits is what we've tested this thing at for quite a while now. So what does that give you? You get improved feed efficiency, improved egg production, improved livability and hatch performance. Plus, you get additional breast meat to live on per animal. Thus, for us it's a really strong asset. It performs nicely. And across a number of quarters during roughly the last 4 or 5 years, we've been fine there; a big bird was missing. We're now in a spot where we've corrected that, and additional upside remains as this fresh genetics line moves through our domestic poultry operation, bringing better yields, better costs, and so on.

Peter Galbo analyst
#12

Perhaps if I could — Donnie, to sharpen the focus on the genetics component. I mean, once more, this isn't a business we tend to hear much about. Could you just sort of orient us again on where this business stands in terms of contributing to EBIT within the Chicken segment, even expressed as a percentage, now compared with where it might have been 5 years back, and maybe it's simply a case of going from losing money to making money; but if you could help us sort of size it up, I believe that would be quite useful for folks as they attempt to grasp it a bit better.

Donnie King executive
#13

Certainly. Appreciate that, Pete. If I look back, and keep in mind, this genetics business, it is — whenever you make adjustments, whenever you make collections, it is a multiyear event; and we have been making those changes, making those adjustments and attempting to — not attempting, but truly delivering a product that — I have to say, all of us are extremely enthusiastic about. Now throughout this timeline, a multiyear timeline, there have been stretches where it has been, okay, there have been stretches where we actually reached a loss in the genetics business, which resides within our domestic poultry business. We are now observing the genetics business truly contributing as those genetics get sold to — currently to Tyson. And what we have not yet observed, Pete, is the effect of those genetics moving through the wider operations and the upside from that is quite meaningful, really significant regarding what impact it will have on not just our domestic chicken business, but the segment overall; so we are extremely enthusiastic about that; we have not discussed that much. It has been early. If I look at, and I cited this figure earlier in response to a previous question, as I examine the bridge on that, roughly 1/3 of our improvement in the quarter is a result — quarter-over-quarter is a result of purely our genetics business. And I would say to you, as you consider how to make that math work, you also need to factor into this bridge the downside to commodity markets; and so it is a fairly significant sum of money that is already contributing, and it will contribute more going forward; but I would say to you that our genetics business, you would need to go back a number of years to see it perform at this level; and I think this — where we stand today will outperform anything we have ever done in our history. But it is a structural advantage to our business.

Peter Galbo analyst
#14

Understood. All right. No, that's quite clear. Curt, I wanted to maybe shift over to Prepared Foods. There's been a bit of talk among your peers, and actually even wider peers in packaged food, regarding inflation when it comes to things like not just freight, but mainly packaging. So I'm just wondering how you view the rest of the year, especially in Prepared and regarding certain input cost dynamics from both a raw material and a packaging perspective?

Donnie King executive
#15

Absolutely. I'll take that one too. Solid execution and pricing discipline when we think about countering inflation — that's our main mitigation tool. We're experiencing inflationary pressure in several input categories. Take feed: grains were a benefit for us during the first half; they might be somewhat higher in the second half. That is factored into our forecast, I'd say; we've had solid execution in our live performance area gains — those gains have more than made up for any feed pressure we've encountered. As for freight, increased freight and diesel expenses are elevated compared to last year. But freight, for us, is a service. In the end, it gets passed along to customers. We don't absorb this cost. Commodity raw materials — think pork, beef, turkey inputs for our Prepared Foods — are elevated; just to provide a figure, Prepared Foods commodity costs rose $50 million in Q2 and $150 million year-to-date. Our pricing keeps catching up to those raw materials. When it comes to packaging, though, resin and packaging input costs are elevated, and we're handling that through value engineering and supplier programs.

Leah Jordan analyst
#16

Congratulations on an excellent quarter, and thank you for the time so far today. I'm just considering Prepared Foods here — you keep picking up share in quite a few of the categories where you compete. I'd love a bit more detail on why you believe that's happening, what you're doing differently from your competitors? And then, what are you observing in the competitive environment at present?

Donnie King executive
#17

Sure. Leah, it's Donnie here. I'll take that one. On that point, we achieved a clean sweep this quarter when it comes to share, with volume, units and dollars all rising at the same time across all 3 measures; but as for our prepared foods, strong demand along with disciplined execution are what's powering the results. You could nearly stop right there. And we've discussed at length our multiyear strategy — that it's delivering and that our business is expanding; we keep managing what we can manage and focus on pricing, promotion, distribution and service. Our volume rose 0.4% in Q2 while sales climbed 4.8%. That marks consecutive quarters of volume growth. For a third straight quarter, we beat the total category. We picked up share in lunchmeat, bacon, snacking and smoked sausage. And regarding how we view that moving forward? I believe you ought to focus on our brands. You ought to focus on protein. You ought to focus on the reality that we hold a pipeline of healthy, nutritious products that satisfy consumer demand in both existing and adjacent categories. We have the assets in place that will deliver meaningful improvement in terms — and we will deliver meaningful improvement in operational excellence and have done so across the last 8 quarters. I'd also note that we're the top performer in packaged, folks. I'd also note that I believe we're undervalued. When you consider us trading at 8x compared with all of the CPG peers out there, I think across recent years and the performance that has taken place, and they've come to us, we haven't gone to them. I don't believe we have grasped the value yet. I've done a bad job conveying the worth of our Prepared Foods within our portfolio and the absolute jewel that it is. And so we are outperforming; it's execution. We follow through on what we commit to. We have the brands and the value added and the mix; and as I mentioned in Chicken, these relationships with these strategic customers and those partnerships win for us every single day. So I'll stop there and see whether you want to redirect.

Leah Jordan analyst
#18

That's really useful context, and the numbers clearly show it. Let's shift gears to Pork care. You mentioned a balanced market is what's backing that up. Could you share more about how confident you are in that guidance range you've kept the same? I suppose, what would it take to reach the top end? It seems like you'd need a fairly significant pickup or gain in the second half?

Devin Cole executive
#19

Yeah. Devin here. Yeah, fair question. Look, I believe a few items worth mentioning might be useful when you're considering the remaining portion of the year. Like you said, we did restate our outlook of $250 million to $300 million; and look, we're set for another really solid year in our Pork operation. When we look at that operation, we keep raising how much raw material we use to fuel the expanding Prepared Foods segment that Donnie brought up. That's among the most critical elements of this for us. Also consider that buyer interest is solid when it comes to our fresh pork and tray pack operation. It remains quite strong and is growing even more so as a relative bargain compared with beef. So we're witnessing robust demand in both foodservice and retail for those items; and if you consider perhaps moving from Q1 into Q2, seasonal patterns play a role there, obviously, Q1 consistently has a fuller schedule. We gain from more hog placements after the holiday, plus some advantageous pricing. Then once you reach Q2, we simply experience the usual ups and downs of our cycle. I'd highlight a few items that might be useful when you're thinking about Q2 compared with where we head next. We did see some effect from elevated hog costs versus the prior year, and then we simply encountered a few specific sources of greater operating expenses that happened during the quarter which we don't expect going forward; we had some excess staffing as we carried out some contingency preparation while immigration status made its way through the process. We received clarity on how that would look; we had some team members relocating whom we were able to successfully shift from our Lexington closure into certain pork assets. We had a number of maintenance and repair issues. And then as you've been told, we had certain weather-related operational effects, but once more, those belong to the quarter. When we look ahead to the rest of the year, extremely positive about this operation overall.

Tom Palmer analyst
#20

Perhaps as a starting point, could you give us an update regarding the shutdown of the beef plant, and share your perspective on what that will mean in the end for profitability during this year, taking into account the greater utilization rates, but also, I believe, certain expenses that might need to be factored in when it comes to transporting product somewhat farther away?

Devin Cole executive
#21

Absolutely, I appreciate that question. Indeed, your point is accurate; we experienced — essentially, what we viewed as the second quarter served as a transitional period for us as we shifted into this fresh harvest footprint; and on top of that, Q2 has always been our most unpredictable quarter when it comes to that specific business. Look, the beef business ahead leaves me feeling positive. There's no point in pretending otherwise that a beef cycle is still underway and the supply situation, with cattle being the primary concern. Yet what I observe from that team is that we've positioned them to genuinely succeed. And I'm witnessing stronger execution, not just in our capacity utilization, but throughout every one of the critical metrics within the end-to-end operational side of that business; I'm also noticing solid consumer demand; we've reached a point now as we head into the latter portion of the year where cut out is actually above where it stood at this same time a year ago. So it seems that consumers, as they sort of shift around that spectrum, possibly moving away from foodservice toward retail and throughout the retail segment, it looks like we're set for a very strong grilling season; so that seems like a genuine upside for us. Yet once more, the gains that we'll realize are tied to the bold choices we made, and those don't truly carry into the second half. We did revise our forecast for the year. But the truth is that even that suggests a fair amount of optimism regarding our capacity to process the cattle that are available and ensure we're running with the best achievable execution when it comes to yield, labor efficiency, capacity utilization, as I mentioned, and above all, mix; but yes, it does indicate an improved second half, without a doubt.

Tom Palmer analyst
#22

Alright. I also wanted to ask a follow-up about the pork segment; when you answered Leah's question, you mentioned that hog costs were higher during the quarter. I realize seasonality plays a role as the year progresses, but we've been hearing about more disease within the herd this winter, and farrowing numbers and intentions have come in fairly light. How do you see the pork supply picture developing through the second half of this year? And how much of that might factor in as we move into either the latter portion of the fiscal year or perhaps even the early months of fiscal 2027?

Devin Cole executive
#23

Yeah, that's a fair point. We're seeing some of those same reports you mentioned, with elevated industry disease, in both bird and CDV. Unfortunately, that's typical for this time of year. The positive side, I'd say, in terms of how we approach this business, is that, first, our supply outlook appears quite stable; and we haven't experienced any disease-related disruptions. I'd credit the strong execution of biosecurity throughout our supply chain and the effort put in there. I believe lot failing is something to monitor; it's certainly not a red flag for us right now; but I think it's something we'll keep watching. Still, when we look at our forecast against our kill schedules and the hogs we've committed within our supply chain, we don't see anything on our end that would be worrying in the back half.

Andrew Strelzik analyst
#24

Donnie, before we go further, one quick point of clarification. At the close of your prepared remarks, you mentioned feeling encouraged by the momentum in the business and seeing opportunities to improve performance. Does that mean you believe there's more room for earnings to rise? Or could you lay out exactly what you were getting at?

Donnie King executive
#25

Sure — across all of our businesses, there is potential for better performance. Just think about continuous improvement. Consider operational excellence from beginning to end. So yes, we've achieved a tremendous amount; the way I see it, this company is fundamentally different today compared with even a year ago, and much stronger. When you put all those pieces together, in my view, it does point to margin expansion being possible. Even more significant, I see the shifts we've made and how we're carrying them out as lasting, not temporary. Every one of our facility networks has been resized appropriately, and we're delivering at a very high standard. Our strategic accounts are on the same page as us. Among the ten biggest protein brands, three belong to us. Beyond that, we're getting product to buyers on schedule and within schedule, and we're bringing new ideas to market to fuel expansion. Here's something that serves as evidence: even within our Prepared Foods segment, when you look at our shoppers, a disproportionate share of them fall into older age brackets. We've started to make inroads with a younger demographic, thanks to certain protein items — or, I should clarify, items that are high in protein. That's something we feel good about, and we view it as an entirely fresh chance within a consumer group. Andrew, I'd add as well that our results are solid. Even so, we've got remaining room in our operations when it comes to poultry and prepared foods, which means we can keep expanding that business without spending heavily on capital. Naturally, demand is what drives all of this for us, and we're eager to move ahead. We also think our volumes will keep climbing in poultry, prepared foods, and likewise in beef and pork. So we're enthusiastic about where we stand. Our performance is strong, and we follow through on our commitments. Because of this, I believe the profit-and-loss results will be fundamentally different in nature. That is something I feel great about.

Andrew Strelzik analyst
#26

Okay, that helps. It might tie into my next question too, and I'm hoping it isn't repetitive. You mentioned there's a lot more to unlock on the Chicken side in terms of benefits, even with this solid improvement in performance. On Prepared, the momentum seems to be building. You mentioned how plant optimization benefits in Beef will build through the year; so I suppose my question is, when you look at total company guidance for this year, what do you believe it captures regarding how far you've come on this internal improvement journey? It feels like things will — should only improve from here past '26, without pinning down a date, but it feels like there's plenty more room left. So I guess we're just interested in hearing your perspective on that.

Donnie King executive
#27

Sure. When I look at it, if you take, for instance, the product mix; we saw volume growth in Chicken, I believe 1.7%. Looking at branded value added, it increased more than 3x; that's exactly where we want it to be; so that's what we've been focused on for quite a while. There are also several actions we're taking regarding simple ingredients within that product, the quality of those items, how consumers experience those items and if you consider our technology efforts and where the market is headed with — from a digital angle, we're growing digital faster than in-store sales by a meaningful margin. So that's where a great deal of growth exists; and so many of the tools and technology we've implemented assist us in linking it with first-party data and communicating directly and, as I mentioned before, especially with those younger consumers; and so all of that feels quite good. When I look at Chicken, it's — we've had 6 straight quarters of growth in both volume and net sales. To me that's a trend. That is structurally different. Prepared Foods 2 consecutive quarters of volume. Third consecutive quarter of having volume growth, unit growth and share or sorry, dollar growth along with that; so if I look broadly and step back a bit, if I look at Chicken, Prepared Foods, Pork and our International business, every one of those is performing very, very well. Our Beef business is performing well on the controllables. I'd argue that perhaps it's as good as it perhaps maybe ever has been, certainly in some time. But we're in the depths of this cycle, the 75-year low cattle cycle. There's nothing we can do about that. I don't — I stay awake and have stayed awake many nights trying to figure out the solution to that. I don't have the solution to that. What I do have the solution for is us controlling what we can control, and that's what we're doing. So overall, I'm feeling quite positive about how we performed across the board, and even more so about how durable that is — about the place we've reached as a company in terms of how well we execute.

Heather Jones analyst
#28

My two questions both concern Chicken. To start, would it be reasonable to claim that because of how large your capacity is, plus the value-added operations and your vertical integration, Tyson holds the strongest cost position? Following on from that, when it comes to the genetics showing up in your meat birds, ought we to anticipate a meaningful boost to that competitive edge?

Donnie King executive
#29

Absolutely. Excellent question. Regarding our Chicken segment, my aim has been shifting how people talk about it — away from a commodity chicken operation and toward one that is genuinely branded and value-added. Our Chicken business, I believe, is not the same as others. Over time, we've demonstrated how it differs when measured against our commodity competitors. That said, I'd quickly repeat what I mentioned before: I don't believe we receive credit for it. Here we are with Chicken trading at 7.5x; take that genetics business I named earlier, which sits within Chicken — genetics companies trade at 20%, 25%, and 20x, 25x, so that gap is quite meaningful. I ran the numbers on it. For Tyson, that comes to roughly $9, $10 per share. So our genetics business has, in my view, always been a distinguishing factor. We ran into some difficulties with it because we lacked a big bird genetics package. And so — well, we have one now. As for the genetics question, let me just work it in here: I'm pleased with where things stand. What you're seeing that differs from recent quarters, though, is the sales from those genetics. If I look back to, say, 2015 or thereabouts, that genetics business would have contributed more than what you've likely observed across the past 4 or 5 years. So I'm pleased with where it stands and, more crucially, with where it's headed. What's still ahead — additional upside for our domestic chicken business — will arrive once those genetics, which we're now placing at scale across this Tyson enterprise, generate substantial segment operating income; possibly more than many would expect; we're pleased about that. Yet even within genetics, what gives me the greatest confidence and conviction is that we're using those exact same genetics while executing with excellence throughout our genetics business and in the domestic and live operations of our poultry business. With all of that working in concert, plus family farmers who perform exceptionally for us, I'm pleased. I'm pleased with the direction we're taking.

Heather Jones analyst
#30

All right. So turning to the back half, and considering the guidance you've provided and the span it covers, particularly in Chicken — last year, Q4 was especially robust, and my sense is conditions for growing were optimal, and so on. But this year, as you pointed out, there are plenty of tailwinds working in your favor. So is there a situation where it would make sense to expect year-over-year improvement in Q4, given everything you've described? Or how should we approach thinking about the sequencing of the back half where Chicken is concerned?

Donnie King executive
#31

Absolutely. Thanks, Heather. To put it briefly, our view is that the back half will match or exceed the first half; we're leaning toward the higher end. Keep in mind, we recently increased guidance by $200 million at the midpoint. We're moving toward the top of that range. So when I consider Q3 and Q4, I'm encouraged. Again, regarding — when you look at what's driving this, let me repeat them. Operational excellence, our portfolio of value-added branded products, our strategic partnerships with customers and our genetics business, all of which will keep contributing and delivering that. We aren't counting on market tailwinds. I mentioned in response to an earlier question that the first half had some tailwinds, but those appear somewhat tougher in the back half, yet I'm confident in our capacity to execute and counterbalance those factors and keep performing. So I believe I've addressed all of those questions.

Curt Calaway executive
#32

Heather, just to jump in on that — clearly, when we raised the range we gave for chicken, that took us to roughly a split that could land at 52% and 48% between the first and second halves, or else 48% and 52%; either way, the year comes out balanced. And of course, we aren't offering any quarterly guidance, so I'll hand it back over.

Donnie King executive
#33

We appreciate you spending part of your day with us and for your ongoing interest in Tyson Foods. We’re eager to update you on how we’re doing when we speak again next quarter.

Operator operator
#34

That brings today's call to a close. We appreciate you joining this presentation. You're free to leave the line now.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Tyson Foods, Inc. transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.

Get an API key View API docs →

For developers and AI pipelines

Programmatic access to Tyson Foods, Inc. earnings transcripts and 132,000+ others is available through the EarningsAPI REST API and the hosted MCP server. Quarterly plans from $162 - full transcripts, speaker segments, full-text search, and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.